INTRODUCTION
Germinal center (GC) responses are crucial for the generation of high-affinity antibodies during T-dependent immune responses. Within the GC resides a specialized subset of CD4 + T cells-the T follicular helper (T fh ) cells-which are essential for GC development and function (1, 2) . It is now clear that T fh cells play a central role in productive vaccine responses, whereas defects in their formation or function can contribute to immunodeficiency or autoimmunity (3, 4) . More recently, the discovery of T follicular regulatory (T fr ) cells, a subset of suppressive regulatory T (T reg ) cells that participate in the GC, added an additional layer of complexity in the biology of GC responses (5) (6) (7) (8) .
T + T reg cells present in lymphoid tissues. Like the T fh cell differentiation pathway, T fr cell commitment requires both dendritic cell and B cell interactions, as well as CD28, SAP (SLAM-associated protein), ICOS (inducible costimulator), and PD-1 (programmed cell death-1) signaling (6, 9, 10) . A tight balance between expression of transcription factors Bcl-6 and Blimp-1 regulates the differentiation of T fr cells (6) . T fr cells have specialized functions in controlling the magnitude of GC responses and in limiting the outgrowth of non-antigen-specific B cell clones (5, 6) . However, the precise mechanisms of T fr cell suppression remain elusive, although cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and regulation of metabolic pathways seem to play a key role (11) (12) (13) .
Although T fh and T fr cells are characterized by their location in lymphoid tissues, an increasing number of studies have described putative circulating counterparts of these cells in peripheral blood. This is particularly relevant for studying the biology of these cells in humans, because access to secondary lymphoid tissues can be limiting. Human blood CXCR5 + T cells have been established as memory T fh -like cells based on their ability to recapitulate bona fide T fh cell functions: Human blood CXCR5 + T cells can promote plasmablast differentiation, activation-induced cytidine deaminase expression, and class switch recombination by naïve B cells. However, they are phenotypically distinct from tissue T fh cells and do not express the transcriptional repressor Bcl-6 (14-16). Furthermore, an immunization leading to GC and antibody responses correlates with an increase in the frequency of circulating ICOS + T fh cells, suggesting that they indicate ongoing T fh cell responses in secondary lymphoid tissues (14, (16) (17) (18) (19) . Human circulating T fh cells comprise a heterogeneous population concerning their phenotype and the quality of help they provide to B cells (14, 17) . In mice, CXCR5 +
Foxp3
+ T fr -like cells were found in peripheral blood after immunization and were shown to represent a circulating counterpart of tissue T fr cells (9, 10) .
Although CXCR5-expressing T reg cells and GC Foxp3-expressing T cells have been found in humans (7, 20, 21) , so far, no studies have addressed the biological importance of these putative circulating T fr -like cells in humans. Human tonsil CD25 
+ T fr cells is unclear (22, 23) . Peripheral blood CXCR5 + T reg cells are being studied as circulating T fr cells in many different human diseases, despite the fact that the biological relevance of these cells is unclear (24-28). Additionally, Foxp3 up-regulation by nonregulatory human T cells and transient CXCR5 expression by T cells undergoing activation challenge the assumption that peripheral blood CXCR5 + T reg cells are bona fide circulating T fr cells (29, 30) .
Here, we found that human blood T fr cells, defined as CXCR5 + Foxp3 + T cells, are generated in peripheral lymphoid tissues as humoral immune responses are established. However, in contrast to tissue T fr cells and conventional CXCR5 − T reg cells, circulating T fr cells have a naïve-like phenotype. Our data demonstrate that blood T fr cells are generated following the initial steps that lead to GC responses being distinct from tissue T fr cells.
RESULTS

Blood T fr cells indicate ongoing GC responses
To address the impact of T fr /T fh ratio in human autoimmunity, we studied Sjögren syndrome (SS), a systemic autoimmune disease characterized by the lymphocytic infiltration of salivary and lachrymal glands, with the formation of ectopic lymphoid structures demonstrating the pathogenic involvement of T-B cell interactions (31, 32) . We studied a cohort of 25 patients with recently diagnosed SS according to American-European Consensus Group (AECG) criteria (33) under no immunosuppressive treatment other than prednisolone (less than 7.5 mg/day or equivalent) or hydroxychloroquine (table S1) . Unexpectedly, we found a notable increased frequency of circulating T fr cells in SS as compared with age-matched healthy donors (HDs) (Fig. 1A and  fig. S1 , A and B). Whereas SS patients showed fewer T reg and T fh cells per milliliter of blood, in agreement with their lymphopenic state ( fig. S1C ), the absolute number of CXCR5 + T fr cells was not different when compared with HDs ( fig. S1B ), in line with the increased frequency of blood CXCR5 + T fr cells. The increased frequency of the CXCR5 + T reg cell subset was specifically increased, providing an explanation for the high T reg cell frequency observed in SS patients (Fig. 1A) . SS patients showed a substantial increase in the T fr /T fh ratio compared with HDs ( Fig. 1B) (8, 10) . Furthermore, among SS patients, the increased T fr /T fh ratio is associated with patients with serum autoantibodies (Fig. 1C) . On the contrary, we found no correlation between high T fr /T fh ratio with C-reactive protein and disease activity score [EULAR Sjögren's syndrome disease activity index (ESSDAI)] (Fig. 1, D tissue samples from the same child ( Fig. 2C and fig. S2B ). We found that circulating T fh cells were phenotypically distinct from their tissue counterparts, in line with previous reports, especially regarding their PD-1, ICOS, and Bcl-6 expression ( Fig. 2C) (14, 15) . In a similar way, circulating CXCR5 − and consequently distinct from tonsil T fr cells (Fig. 2C ). In addition, we confirmed that these cell populations displayed a similar phenotype in adults ( fig. S2, C and D) . Our results are consistent with murine studies showing that blood and tissue T fr cells are phenotypically distinct (9) . ICOS was not differentially expressed by T reg and T fr cells in tonsils (Fig. 2C ). Bcl-6 expression was not detected in any population by real-time polymerase chain reaction (PCR) (fig. S1F), consistent with previous reports showing that blood T fh cells do not express 34) . We also confirmed that tissue CXCR5 +
Foxp3
+ T cells are localized within GCs, therefore corresponding to T fr cells ( Fig. 2D and fig. S2G ). Curiously, we observed different T fr /T fh ratios in the blood and tonsils (Fig. 2E ).
CXCR5
+
Foxp3
+ T fr cells are a distinct subset of suppressive Foxp3 + T cells It has been described that CXCR5 expression can transiently occur upon human T cell activation (30, 35, 36) . Moreover, human T cells can also transiently express Foxp3 upon in vitro T cell receptor (TCR) stimulation in a transforming growth factor- (TGF-)-dependent manner (29, 37) . (Fig. 3A) . Blood CXCR5 +
+ T fr cells reduced conventional T cell proliferation (Fig. 3 , B and C), definitely demonstrating their regulatory function.
Stability of Foxp3 expression is required for the suppressive function of T reg cells (38) . To determine whether blood T fr cells have stable Foxp3 expression, we stimulated sorted T fr cells and CXCR5 − T reg cells with anti-CD3/CD28 microbeads for 5 days in the absence of exogenous interleukin-2 (IL-2). In the absence of IL-2, T reg cells do not survive well in culture. Under these conditions, both CXCR5
− T reg cells and T fr cells retain a similar frequency of Foxp3 + cells, albeit lower than in the beginning of the culture (Fig. 3D ). The frequency of recovered live Foxp3-expressing cells was slightly higher for sorted T fr cells as compared with CXCR5 − conventional T reg cells. Next, we analyzed the relative expression of Foxp3 and CXCR5 in sorted conventional T cells, T fh cells, T fr cells, and CXCR5
− T reg cells from human blood by real-time PCR. Although Foxp3 protein expression was lower in T fr cells than in CXCR5 − T reg cells ( Fig. 2C and fig. S2D ), Foxp3 gene expression was similar between the two subsets (Fig. 3E ). In addition, circulating T fh and T fr cells also showed comparable CXCR5 gene expression (Fig. 3E) .
To investigate whether activation of blood T fr cells triggers upregulation of Foxp3, CD25, and CTLA-4, a phenomenon known to be associated with increased T reg cell-suppressive function (38), we analyzed the phenotype of sorted CXCR5 + and CXCR5 − T reg cells after 5 days of culture in the presence of CD3/CD28 microbeads. We found an up-regulation of Foxp3 and CD25 by T fr cells, whereas CTLA-4 was increased in both populations ( Fig. 3F and fig. S3C ). The levels of expression of these markers by blood T fr cells after activation resembled those from tissue T fr cells (compare with Fig. 2C ). CXCR5 up-regulation was not detected in sorted CXCR5 − T reg cells, showing that CXCR5 + T fr cells are a distinct subset of human blood T reg cells.
Blood T fr cells do not preferentially suppress humoral responses
To address the function of blood T fr cells, we first investigated whether this population could directly suppress T fh cells. Using a similar in vitro assay used to prove the regulatory capacity of blood T fr cells, but with sorted T fh cells as responders, we found that blood T fr cells strongly suppressed T fh cell proliferation, but without a specific advantage when compared with CXCR5 − T reg cells (Fig. 4A ). Next, to directly assess the impact of blood T fr cells on B cell activation, we used in vitro T-B cocultures in the presence of staphylococcal enterotoxin B (SEB) superantigen ( To further address the function of blood T fr cells on humoral responses, we analyzed class switch recombination by naïve B cells 10 days after superantigen stimulation. We found that blood T fr cells, although able to reduce activation of naïve B cells and proliferation of T fh cells as shown before, did not limit class switch recombination by B cells because no impact on IgA or IgG production was observed (Fig. 4E) . On the contrary, CXCR5
− T reg cells efficiently suppressed humoral responses (Fig. 4E) .
CXCR5/CXCL13-dependent migration to GC is critical for suppression of humoral responses by T fr cells (5, 7) , and plasma CXCL13 levels have been correlated to ongoing GC responses in humans (39) . To prove that blood T fr cells were capable of migrating toward a CXCL13 gradient, we conducted in vitro chemotaxis assays with sorted populations from human peripheral blood. We found that, although the CXCR5 mean fluorescence intensity (MFI) of peripheral T fh and T fr cells was slightly different (Fig. 2C and fig. S2D ), both populations shared their ability to migrate toward a CXCL13 gradient, showing functional capacity of blood T fr cells to enter CXCL13-enriched tissues (Fig. 4F ).
Blood T fr cells have a distinctive naïve-like phenotype
To explain the unexpected observation that blood T fr cells do not suppress antibody production, we hypothesized that this population could represent thymus-derived precursors of T fr cells not yet fully committed to regulate humoral responses. We found that blood T fr cells were predominantly CD45RO − Foxp3 lo resting T reg cells (Fig. 5A ), expressing high levels of CD45RA, CCR7, CD62L, and CD27 and low levels of human leukocyte antigen-DR (HLA-DR), reminiscent of a naïve phenotype (Fig. 5B) . Virtually, all blood T fr cells were quiescent Ki-67 − nonproliferating cells when analyzed ex vivo (Fig. 5C ). Moreover, circulating T fr cells were virtually devoid of CD45RO + CCR7
− effector memory cells, in notable contrast to CXCR5 − T reg cells, a phenotype more similar to circulating T fh cells (Fig. 5D ). Although the vast majority of blood T fh cells were CD45RO + CCR7
+ central memory cells, consistent with previous reports (14-17), a substantial proportion of T fr cells were CD45RO − CCR7
+ naïve cells (Fig. 5D ). Furthermore, the few CD45RO − T fh cells did not express high levels of CD45RA, indicating that those cells were not really naïve, in contrast to T fr cells ( fig. S5A ). Therefore, blood T fr cells constitute a pool of naïve resting cells.
To test whether blood T fr cells were thymus-derived pre cursors of tissue T fr cells, we analyzed the frequency of these cells according to age. Contrary to thymus-derived naïve T reg cells, CD45RO − CCR7 + naïve T fr cells did not decrease with increasing age (Fig. 5E ). In addition, the expression of CD31, a marker used to identify recent thymic emigrants in human blood (40) (41) (42) , was not specifically enriched in the population ( fig. S5 , B and C). Although these observations suggest that blood T fr cells are not a thymic population, this was not conclusive. Therefore, we directly examined CXCR5-expressing T cells in the human thymus and neonatal cord blood. There was not a population of CXCR5 + T reg cells detected in any of those tissues (Fig. 5, F  and G, and fig. S5D ). Although CXCR5-expressing T reg cells were not found in cord blood, some Foxp3 + cells expressed CD45RO, suggesting that additional activation signals not present before birth are required to shape a CXCR5 phenotype in circulating T reg cells. Consistent with our previous data, ICOS + T reg cells were detected in cord blood, indicating that ICOS cannot be used as a specific follicular marker in circulating human T reg cells (Fig. 5H ).
Blood T fr cells emerge from lymphoid organs before B cell interaction
Having demonstrated that circulating T fr cells did not egress from the thymus, we investigated whether T fr cells recirculate from secondary lymphoid tissues before being fully committed to tissue T fr cells. We compared both CXCR5 + and CXCR5 − T reg cell subsets from children paired blood and tissue (tonsils) concerning their effector memory, central memory, and naïve composition. We found that CD45RO + CCR7
− effector T fr cells were present in lymphoid tissues but not in the blood, suggesting that effector T fr cells are selectively retained in tissues, similarly to effector T fh cells (Fig. 6A) . Therefore, it is unlikely that blood CD45RO − T fr cells derive from the fully mature tissue T fr cells that express CD45RO, as the few CD45RA re expressing end-stage memory CD4 + T cells do not become CD45RO − ( fig. S6A ) (43, 44) .
Our data suggest that blood T fr cells are generated in secondary lymphoid tissue before full differentiation toward mature T fr cells. It has been known that full differentiation of follicular T cells requires a two-step process, with an initial activation mediated by dendritic cells and a subsequent B cell interaction in the T-B border. We investigated whether blood T fr cells, given their immature phenotype, could be generated before the B cell interactions required for acquisition of terminal differentiation. To investigate this issue, we analyzed peripheral blood from X-linked agammaglobulinemia [Bruton's tyrosine kinase (BTK)-deficient] patients, with a complete absence of CD19 + cells. We observed a notable decrease in blood T fh cells in those patients, in line with previous reports (Fig. 6B) (45) . However, frequency of blood T fr cells was not decreased in B cell-deficient patients (Fig. 6B) . These observations are conclusive in establishing that blood T fr cells enter the circulation before B cell contact, whereas most of the blood T fh cells require B cell interactions. To investigate whether CD45RO + and CD45RO − blood T fr cells could discriminate between T fr cells recirculating before and after B cell interaction, we analyzed these two populations in peripheral blood of patients with B cell deficiency, as well as in SS patients. We found no differences in CD45RO + or CD45RO
− T fr cells in these two diseases ( fig. S5E ), although CD45RO up-regulation occurs irrespective of B cell interaction on T fr cells. We therefore hypothesized that blood T fr cells are generated in secondary lymphoid tissue and enter the circulation before full differentiation toward tissue T fr cells (Fig. 6C) . To test our model in vivo, we analyzed samples from healthy adults undergoing influenza vaccination. Previous studies have shown a positive correlation between circulating T fh cell subsets and antibody responses after influenza vaccination in healthy adults (15, 18, 19) . We therefore analyzed the impact of vaccination in circulating T fr cells. Consistent with our hypothesis, we found that circulating T fr cells increased on day 7 after influenza vaccination (Fig. 6D) . This observation is in line with our prediction that, during ongoing GC responses, T fr cells are generated and some exit from the tissue to the peripheral blood. T reg cells, are increased in those patients. As a consequence, the apparent increase of T reg cells in the blood of SS patients is an increase of CXCR5 + T fr cells that reflect the ongoing humoral activity. It was the search for an explanation for this apparent counterintuitive observation that led us to establish the ontogeny and function of human circulating T fr cells.
DISCUSSION
We found that T fr cells in tonsils have follicular and regulatory markers and were found within GCs, whereas blood T fr cells do not express ICOS, PD-1, or Bcl-6, apparently diverging these cells from follicular imprinting. Previous studies have described low ICOS and PD-1 expression and no Bcl-6 expression in human blood T fh cells (14) . In mice, blood T fr cells have also lower expression of ICOS (9) . It was also reported that murine circulating T fr cells can bypass the B cell zone and do not gain full activation as part of a memory programmed state (9) . In line with these studies, the absence of ICOS, PD-1, and Bcl-6 from human blood CXCR5 + T fr cells does not exclude their follicular ontogeny.
Our results show key differences between mice and humans regarding the function of blood CXCR5 + T fr cells: Although murine blood T fr cells appear to be specialized in suppressing antibody production (despite their lower suppressive capacity when compared with tissue T fr cells) (9, 10, 12, 13) , human blood T fr cells do not have the ability to fully suppress humoral responses.
Nevertheless, we found that blood T fr cells specifically migrated toward CXCL13 gradient, suggesting that these cells have the capacity to reach the follicles. CXCR5 − conventional T reg cells did not up-regulate CXCR5 upon in vitro activation, further confirming CXCR5-expressing T fr cells as a distinctive subset.
We also found that blood T fr cells have a prominent naïve phenotype. However, they are absent from the thymus and cord blood (where activated T reg cells can already be found). Our results from vaccination and SS patient cohorts show that blood T fr cells are indicative of ongoing humoral activity. In SS patients, where ongoing GC reactions promote the production of autoantibodies (31, 32) , blood T fr cells were substantially increased (directly contributing to an increased T fr /T fh ratio). Although we expected to find a decrease in this putative humoral suppressive cell population in autoimmune conditions, our results suggest that blood T fr cells indicate ongoing humoral activity and are not a measurement of suppressive potential. This is in line with recently published reports showing an increase in blood CXCR5
+ T reg cells in other autoimmune conditions and infectious diseases (27, 28, 47) . Therefore, studies regarding blood CXCR5 + T reg cells in different human settings should be carefully interpreted.
Given that circulating T fr cells have an immature phenotype, it is not unexpected that blood T fr cells are not fully endowed with suppressive function, because the suppressive capacity of conventional T reg cells has been ascribed predominantly to those cells with a more mature phenotype. Although the TCR repertoire of T fr cells is different from T fh and probably skewed toward autoantigens (48), it is possible that circulating T fr cells represent a pool of cells ready to be recruited into subsequent GC responses as they retain the ability to migrate toward CXCL13.
In conclusion, our data support a model in which CXCR5 
MATERIALS AND METHODS
Study design
Sample sizes were estimated on the basis of previous studies and according to each cohort (see the next section). No outliers were excluded. The number of biological and technical replicates is stated in the figure legends. Human samples from different conditions were used (see the next section) with appropriate age-matched controls. This experimental study was performed unblinded.
Human samples
Fresh peripheral blood samples were collected from patients referred to the Rheumatology Department of Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, for salivary gland biopsy due to clinical suspicion of SS. Blood samples were collected on the day of salivary gland biopsy. All patients with exclusion criteria for SS (33) or treated with biologic drugs, disease-modifying antirheumatic drugs, or prednisolone (more than 7.5 mg/day) were excluded. Patients diagnosed with an infectious disease in the previous month were also excluded, as well as those who received any vaccine in the same period of time. Patients were diagnosed as having SS if they met the AECG diagnosis criteria (n = 25) (33) . Routine C-reactive protein plasma levels (mg/dl) closest to blood collection were used. Age-matched healthy volunteers (from the cohort described below) were used for statistical comparison. Fresh peripheral blood samples were collected from healthy adult volunteers (n = 42). Fresh buffy coats (blood collection in less than 24 hours) were used for in vitro suppression and coculture assays. Tonsils and peripheral blood samples were collected from healthy children submitted to tonsillectomy due to tonsil hypertrophy (n = 6). Children with any clinical condition, under any drug treatment, or submitted to tonsillectomy due to chronic tonsillitis were excluded. Umbilical cord blood samples were collected from healthy pregnant women during delivery (n = 3). Thymus tissue was collected from children submitted to cardiac surgery due to congenital heart disease who were otherwise healthy (n = 4). Blood samples were also collected from X-linked agammaglobulinemia (BTK-deficient) patients during routine blood tests (n = 5). All blood samples were collected in EDTAcoated tubes. These studies were approved by the Lisbon Academic Medical Center Ethics Committee (reference no. 505/14). Informed consent was obtained from all adult volunteers, parents, or legal guardians.
For vaccination studies, we used healthy adult volunteers (n = 32) recruited from the Cambridge BioResource as part of the vaccination study during the 2014-2015 winter season. Participants were excluded if they have had a previous adverse reaction to any vaccination, have a known allergy to any components of the vaccine, were taking immunomodulating medication, and are pregnant or breastfeeding. Participants were administered the inactivated influenza vaccine (split virion) BP vaccine (Sanofi Pasteur) by intramuscular injection in the right deltoid. Blood samples were collected in EDTA-coated tubes on the day of vaccination (before administration of the vaccine) and 7 days after vaccination. The influenza vaccination study protocol was approved by the Health Research Authority, National Research Ethics Service Committee South Central, Hampshire A, UK (REC reference: 14/SC/1077).
Cell isolation and flow cytometry
Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples by Ficoll gradient medium (Histopaque-1077, Sigma-Aldrich) using SepMate tubes (STEMCELL Technologies). Lymphocytes from tonsils and thymocytes were also isolated by Ficoll gradient medium after mechanical disruption. Before cell sorting, PBMCs from buffy coats were enriched for CD4 + T cells using MojoSort Human CD4 T Cell Isolation Kit (BioLegend). The CD4 + fraction was used for cell sorting of CD4 + T cell subsets. The CD4 − fraction was used for cell sorting of naïve B cells (see fig. S1A for sorting strategy). + naïve B cells. Cells were cultured with SEB (1 g/ml) (Sigma-Aldrich) + staphylococcal enterotoxin A (SEA) (10 ng/ml) (Toxin Technology) + staphylococcal enterotoxin E (SEE) (10 ng/ml) (Toxin Technology) + toxic shock syndrome toxin-1 (TSST-1) (10 ng/ml) (Toxin Technology). After 10 days, supernatants were collected and immunoglobulin concentration was determined by enzymelinked immunosorbent assay (ELISA). Cultures were performed in U-shaped 96-well plates in RPMI 1640 (Life Technologies) supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies), 1% Hepes (Sigma-Aldrich), 1% sodium pyruvate (Life Technologies), 1% penicillin-streptomycin (Life Technologies), and 0.05% gentamicin (Life Technologies) in 37°C, 5% CO 2 incubator conditions.
Enzyme-linked immunosorbent assay
IgA, IgM, and total IgG concentrations were determined in supernatants from T-B coculture (as described above) by ELISA using Human ELISA Ready Set Go Kit according to the manufacturer's instructions (eBioscience). G6PD) and calculated by change-in-threshold method (C T ) using QuantStudio Real-Time PCR software v1.1 (Applied Biosystems). The following primers (Invitrogen) were used: Foxp3, 5′-GCAAATGGTGTCTGCAAGTG-3′ (forward) and 5′-GCCCTTCT-CATCCAGAAGAT-3′ (reverse); CXCR5, 5′-CTGGAAATGGACCTC-GAGAA-3′ (forward) and 5′-GCAGGGCAGAGATGATT TTC-3′ (reverse); Bcl-6, 5′-TTCCGCTACAAGGGCAAC-3′ (forward) and 5′-CGAGT-GTGGGTTTTCAGGTT-3′ (reverse); B2M, 5′-TATGCCTGCCGTGT-GAACCAT-3′ (forward) and 5′-CGGCATCTT CAAACCTCCATG-3′ (reverse); ACTB, 5′-CTCTTCCAGCC T TCCTTCCT-3′ (forward) and 5′-AGCACTGTGTTGGCGTACAG-3′ (reverse); G6PD, 5′-CCAAG-CCCATCCCCTATATT-3′ (forward) and 5′-CCACTTGTAGGTGC-CCTCAT-3′ (reverse).
Migration assays
Immunofluorescence microscopy
After paraffin removal and antigen retrieval by heat (HIER pH 9, Leica Biosystems), 3-m sections of formalin-fixed, paraffin-embedded human tonsil were stained with anti-human CXCR5-Alexa Fluor 488 (J252D4, BioLegend), anti-human CD4 (SP35, Cell Marque), and anti-human Foxp3 (PCH101, eBioscience) primary antibodies. Alexa Fluor 488 (anti-mouse), Alexa Fluor 546 (anti-rabbit), and Alexa Fluor 488 (anti-rat) were used as secondary antibodies. 4′,6-Diamidino-2-phenylindole (DAPI) was used as nuclei counterstaining. Images were acquired with ZEN 2012 software on a Zeiss LSM 710 confocal point-scanning microscope (Carl Zeiss) using a dry Plan-Apochromat 20× objective (×200 magnification) and with a numerical aperture of 0.80. Images were further analyzed using ImageJ Fiji software.
Statistical analysis
Unpaired, paired Student's t test, one-way analysis of variance (ANOVA) with posttest Turkey's multiple comparisons, and two-way ANOVA with posttest Bonferroni's multiple comparison were used as described. Linear regression analysis was also conducted for some data. Results are presented as means ± SD. P values of less than 0.05 were considered statistically significant. GraphPad Prism v5 software was used for statistical analysis.
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